Review of the Potential Role of Ascorbate in the Prevention and Treatment of Gynecological Cancers
X Shen, J Wang, B Deng, Z Zhao, S Chen, W Kong… - Antioxidants, 2024 - mdpi.com
Ascorbate (vitamin C) is an essential vitamin for the human body and participates in various
physiological processes as an important coenzyme and antioxidant. Furthermore, the role of …
physiological processes as an important coenzyme and antioxidant. Furthermore, the role of …
[HTML][HTML] The Effects of Gynecological Tumor Irradiation on the Immune System
J Romero Fernandez, S Cordoba Largo… - Cancers, 2024 - mdpi.com
Simple Summary Radiobiology has evolved from a mechanistic model based on DNA
damage, and other response factors, into a more complex model including effects on the …
damage, and other response factors, into a more complex model including effects on the …
Characterizing impact of positive lymph node number in endometrial cancer using machine-learning: A better prognostic indicator than FIGO staging?
Background Number of involved lymph nodes (LNs) is a crucial stratification factor in staging
of numerous disease sites, but has not been incorporated for endometrial cancer. We …
of numerous disease sites, but has not been incorporated for endometrial cancer. We …
From Satirical Poems and Invisible Poisons to Radical Surgery and Organized Cervical Cancer Screening—A Historical Outline of Cervical Carcinoma and Its …
L Jung, GG Klamminger, B Bier, E Eltze - Life, 2024 - mdpi.com
Over the last century, the narrative of cervical cancer history has become intricately tied to
virus research, particularly the human papillomavirus (HPV) since the 1970s. The …
virus research, particularly the human papillomavirus (HPV) since the 1970s. The …
[PDF][PDF] From New Molecular Insights to New Treatment Options in Endometrial Cancer
U Hasler-Strub - healthbook TIMES Oncology …, 2022 - onco-hema.healthbooktimes.org
Endometrial cancer remains the most common gynecological cancer in Europe and the US,
with excellent survival rates in patients with early-stage disease.^ 1^ However, the prognosis …
with excellent survival rates in patients with early-stage disease.^ 1^ However, the prognosis …
多靶点小分子酪氨酸激酶抑制剂联合免疫检查点抑制剂治疗标准治疗方案失败后晚期实体瘤患者的效果.
梁丹， 易颖， 黄为福， 农先胜 - Journal of Practical Medicine …, 2024 - search.ebscohost.com
目的研究多靶点小分子酪氨酸激酶抑制剂(MTKIs) 和免疫检查点抑制剂(ICIs)
联合治疗对标准治疗方案失败的晚期实体瘤患者的临床疗效与安全性. 方法选择2021 年1 …
联合治疗对标准治疗方案失败的晚期实体瘤患者的临床疗效与安全性. 方法选择2021 年1 …
免疫检查点抑制剂在妇科恶性实体肿瘤中的研究进展.
刘德高， 张舒荣， 高悦文， 邹永辉… - Journal of International …, 2022 - search.ebscohost.com
妇科恶性实体肿瘤严重威胁女性生命健康, 晚期, 复发性及转移性妇科肿瘤的放化疗等辅助治疗
效果欠佳, 预后较差. 近年来, 以免疫检查点抑制剂为主的免疫疗法在恶性实体肿瘤的治疗中显示 …
效果欠佳, 预后较差. 近年来, 以免疫检查点抑制剂为主的免疫疗法在恶性实体肿瘤的治疗中显示 …
CLL and Lymphoma Studies at EHA2021 and 16-ICML
D Rossi - healthbook TIMES Oncology …, 2021 - onco-hema.healthbooktimes.org
The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal
disorders caused by somatic driver mutations affecting the hematopoietic stem and …
disorders caused by somatic driver mutations affecting the hematopoietic stem and …
With regards to Ellsworth et al. on “Lymphocyte sparing normal tissue effects in the clinic LymphoTEC): A systematic review of dose constraint considerations to …
BP Venkatesulu, P Giridhar - Radiotherapy and Oncology, 2023 - thegreenjournal.com
We read with interest about Ellsworth et al. letter to the editor on our article ''Lymphocyte
sparing normal tissue effects in the clinic (LymphoTEC): a systematic review of dose …
sparing normal tissue effects in the clinic (LymphoTEC): a systematic review of dose …